اوقات شرعی

معاون پژوهش و فناوری دانشگاه

 

 
 
 
دكتر محسن تفقدی

(PharmD, PhD)

عضو هیئت علمی گروه فارماسیوتیکس  و نانوفناوری دانشکده داروسازی مشهد
 
 
 

 
 
 
 
 

 

Curriculum Vitae

 

Mohsen Tafaghodi (Pharm.D., Ph.D.)

 Professor in Pharmaceutics and Nanotechnology,

School of Pharmacy,

Nanotechnology Research Center,

Mashhad University of Medical Sciences,

Mashhad-Iran

P.O. Box:  91775-1365

Phone: ++98-51-38823255-66 (Office)

Fax: ++98-51-38823251

E-mail: این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید

 

Education and training

Pharm.D.: School of Pharmacy, Mashhad University of Medical Sciences (1991-1997).

Ph.D. (Pharmaceutics): School of Pharmacy, Mashhad University of Medical Sciences (1997-2003).

Ph.D. thesis title: Nasal immunization using biodegradable microspheres and liposomes: Tetanus toxoid as a model

Research fellowships:

1-      School of Pharmacy, University of Alberta, Canada (cancer vaccination using nano- and microparticulate drug delivery systems).

2-      Leiden/Amsterdam center for Drug Research, University of Leiden, Netherland (preparation and characterization and in vivo study of TMC:HBsAg and chitosan:HBsAg nanoparticles as a nasal delivery /adjuvant system)

 

Research Interest

-          Mucosal and systemic vaccine and drug delivery by nanoparticulate and microparticulate delivery systems (nanospheres, microspheres and liposomes)

 

Honors & Awards

Honored investigator (student) in medicinal sciences, Ferdowsi Festival, Mashhad, 2001 (Offered by MUMS and FUM).

Honored Pharmacist, Mashhad, 2002 (Offered by Khorasan Association of Pharmacists).

The best presentation in 8th Iranian Seminar of Pharmaceutical Scientists (Ph.D. student), Shiraz, 2002 (Offered by Iranian Association of Pharmaceutical Scientists).

Honored young researcher, 9th Iranian Seminar of Pharmaceutical Sciences, Tabriz, 2004 (Offered by Iranian Association of Pharmaceutical Scientists).

The best book translation (Adverse effects of herbal drugs vol. 1 and 2), Research week festival, Mashhad, 2004 (Offered by MUMS)

Three awards from Iranian Nanotechnology Initiative for supervision of two Pharm.D. thesis.

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2006 (Offered by MUMS)

Honored lecturer, MOALEM week festival, Mashhad, 2007 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Tehran, 2007 (Offered by University of Tehran)

The best book translation (Pharmaceutics, vol. 2), Research week festival, Mashhad, 2007 (Offered by MUMS)

The best presentation in ICRC 2011, Mashhad, 2011 (Offered by Iranian Controlled Release Society).

The best book translation (Nonprescription Drug Therapy), Research week festival, Mashhad, 2011 (Offered by MUMS)

The best book translation (Pharmaceutics, vol. 1), Research week festival, Mashhad, 2015 (Offered by MUMS).

 

Memberships

Member of “Nanotechnology Research Center”, Mashhad University of Medical Sciences

Member of “Controlled Release Society of Iran”

Editorial member of Asian Pacific Journal of Tropical Medicine (2009-2011; 2016-now)

Editorial member of Nanomedicine Journal

Reviewer of Drug Development and Industrial Pharmacy journal

Reviewer of Journal of Drug Targeting

Reviewer of Journal of Microencapsulation

Reviewer of Journal of the Taiwan Institute of Chemical Engineers

Reviewer of Iranian Journal of Pharmaceutical Research

Reviewer of Iranian Journal of Basic Medical Sciences

Reviewer of DARU journal

Reviewer of Colloids and Surfaces, B journal

 

Workshops:

Member of “Nanotechnology Research Center”, Mashhad University of Medical Sciences

Member of “Controlled Release Society of Iran”

Editorial member of Asian Pacific Journal of Tropical Medicine (2009-2011; 2016-now)

Editorial member of Nanomedicine Journal

Reviewer of Drug Development and Industrial Pharmacy journal

Reviewer of Journal of Drug Targeting

Reviewer of Journal of Microencapsulation

Reviewer of Journal of the Taiwan Institute of Chemical Engineers

Reviewer of Iranian Journal of Pharmaceutical Research

Reviewer of Iranian Journal of Basic Medical Sciences

Reviewer of DARU journal

Reviewer of Colloids and Surfaces, B journal


Patents

US patent : chimeric peptides against HTLV-1

 

Publishes and presentations

Books

1. Tafaghodi, M., Amiri, R., Hosseinzadeh, H., 1998. Adverse Effects of Herbal Drugs. Volume 1, MUMS Press, Mashhad. (Translation), 4th print 2007.

2. Tafaghodi, M., Hosseinzadeh, H., 2002. Adverse Effects of Herbal Drugs. Volume 2, MUMS Press, Mashhad. (Translation), 3rd print, 2007.

3. Hosseinzadeh, H., Tafaghodi, M., 2006. Adverse Effects of Herbal Drugs. Volume 3, MUMS Press, Mashhad. (Translation).

4. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., 2006. Pharmaceutics, the science of dosage form design. Volume 1, MUMS Press, Mashhad. (Translation, 2nd print, 2009).

5. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2007. Pharmaceutics, the science of dosage form design. Volume 2. (Translation), 2nd print, 2010.

6. Imenshahidi, M., Moallem, S.A., Tafaghodi, M., Rezaei, Ramin, Firouzi, Zohreh, 2011. Nonprescription Drug Therapy. MUMS press, Mashhad. (Translation)

7. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmaceutics, the design and manufacture of medicines. Volume 1, MUMS Press, Mashhad. (Translation, 2015).

8. Afrasiabi, H., Tafaghodi, M., Sajadi, S.A., Sadeghi, F., Fazly, B.S., 2013. Aulton’s Pharmaceutics, the design and manufacture of medicines. Volume 2, MUMS Press, Mashhad. (Translation, 2015).

 

Papers

 1- Diwan, M., Tafaghodi, M., Samuel, J., 2002. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. Journal of Controlled Release, 85, 247-262

2- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Drug delivery from nasal route. Razi,, 155, 32-42.

3- Tafaghodi, M., Hasanzadeh, M., Rahimizadeh, M., 2003. Isolation and identification of Hyoscyamus insanus alkaloids. Iranian journal of Medicinal Plants, 2(7), 29-36.

4- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Utilization of particulate and immuno-modulating adjuvants for enhancement of immune responses against tumors antigenic markers. Iranian Journal of Basic Medical Sciences, 6(4), 336-345.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., Zakavi, S.R., Momen-nejad, M., 2004. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. International Journal of Pharmaceutics, 280, 125-135.

6- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2004. Mucosal immunization. Razi, 175, 17-24.

7- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2004. Adjuvants. Razi, 174, 34-45.

8- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2004. Dextran microspheres encapsulated with tetanus toxoid as a delivery system for nasal immunization: in vitro and in vivo characterization.  Iranian Journal of Basic Medical Sciences, 7(2), 88-98.

9- Jaafari, M.R., Tafaghodi, M., Sajadi Tabasi, S.A., 2005. Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy. Iranian Journal of Pharmaceutical Research, 4(1), 3-11.

10- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Formulation and characterization and release studies of alginate microsphere encapsulated with tetanus toxoid. Journal of Biomaterials Science. Polymer Edition., 17(8), 909-924.

11- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2006. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. International Journal of Pharmaceutics, 319, 37-43.

12- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2006. Nasal immunization studies by liposomes encapsulated with tetanus toxoid and CpG-ODN. European Journal of Pharmaceutics and Biopharmaceutics, 64, 138-145.

13- Tafaghodi, M., Jaafari, M.R., Nikouzadeh, A. 2007. Evaluation of systemic and mucosal immune responses following the nasal immunization by various sizes of liposomes encapsulated with tetanus toxoid. Iranian Journal of Basic Medical Sciences, 9, 4(32), 307-315.

14- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2007. Nasal immunization study by PLGA nanospheres encapsulated with tetanus toxoid and CpG-ODN. Iranian Journal of Pharmaceutical Research, 6(3), 151-158.

15- Ghiasi, Z., Sajadi Tabasi, S.A., Tafaghodi, M., 2007. Preparation and In Vitro  Characterization of Alginate Microspheres Encapsulated with Autoclaved Leishmania major (ALM) and CpG –ODN. Iranian Journal of Basic Medical Sciences, 10(2), 90-98.

16- Tafaghodi, M., Sajadi Tabasi, S.A., Payan, M., 2007. Alginate microspheres as delivery system and adjuvant for autoclaved Leishmania major (ALM) and Quillaja saponin (QS) - Preparation and characterization. Iranian Journal of Pharmaceutical Sciences, 3(2), 61-68.

17- Nazemian, F., Mohammad-Poor, A-H, Naghibi, M, Hasanzadeh-Khayat, M., Tafaghodi, M., Charkazi, S, Abrisham, S., 2007. The effect of pentoxiphylline on hemoglobin levels in patients with erythropoietin resistant anemia in hemodialysis patients. Nephrology Dialysis Transplantation, 22(Supplement 6), 355-355.

18- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2008. Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid. Current Drug Delivery, 5, 108-113.

19- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2008. Preparation and characterization of PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and Quillaja saponin. Saudi Pharmaceutical Journal, 16(1), 43-49.

20- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R., 2008. Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran  microspheres. International Journal of Pharmaceutics, 360, 12-17.

21- Tafaghodi, M., Hadizadeh, F., Farahmand, F., 2008. Determination of encapsulation efficiency of tetanus toxoid in microsphere and liposome drug delivery systems by two different spectroscopic methods, Pharmaceutical Sciences, summer, 53-59.

22- Tafaghodi, M., Sajadi Tabasi, S.A., Amiri, N., 2008. PLGA nanospheres loaded with Autoclaved Leishmania Major (ALM) and CpG-ODN: Preparation and in vitro characterization. Iranian Journal of basic medical Sciences, 11(2), 112-119.

23- Deldar, K., Nazemi, E., Balali Mood, M., Emami, S.A., Mohammadpour, A.H., Tafaghodi, M., Afshari, R., 2008. Effect of Coriandrum sativum L. extract on lead excretion in 3-7 year old children, Journal of Birjand University of Medical Sciences, 15, 11-19.    

24- Amin, M.R., Jaafari, M.R., Tafaghodi, M., 2009. Nasal immunization studies in rabbits by anionic and chitosan coated liposomes encapsulated with tetanus toxoid as a model antigen. Colloids and Surfaces B. Biointerfaces, 74, 225-229.

25- Khadivzadeh, T., Samadi, S., Emami, A., Tafaghodi, M., Sanjar Moosavi, N., Behnam, H.R., 2010. The Effect of Hypericum Perforatum on the Wound Healing and Scar of Cesarean. Journal of Alternative and Complementary Medicine, 16(1), 113-117.

26- Tafaghodi, M., Rastegar, S., 2010. Preparation and in vivo study of dry powder microspheres for nasal immunization. Journal of Drug Targeting, 18(3), 235-242.

27- Emami, S.A., Fakhrjafary, M., Tafaghodi, M., Hassanzadeh, M.K., 2010. Chemical Composition and Antioxidant Activities of the Essential Oils of Different Parts of Cupressus arizonica Greene. Journal of Essential Oil Research, 22, 193-199.

28- Tafaghodi, M., Jaafari, M.R., Eskandari, M., Khamesipour, A., 2010. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental Autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27, 639-650.

29- Alipour, S., Montaseri, H., Tafaghodi, M., 2010. Preparation and characterization of paclitaxel loaded alginate microparticles for pulmonary delivery. Colloids and Surfaces B. Biointerfaces, 81, 521-529.

30- Mohaghegh, M., Tafaghodi, M., 2011. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. Pharmaceutical Development and Technology, 16, 36-43.

31- Tafaghodi, M., Khamesipour, A., Jaafari, M.R., 2011. Immunization against leishmaniasis by PLGA nanospheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108, 1265-1273.

32- Tafaghodi, M., Eskandari, M., Khamesipour, A., Jaafari, M.R., 2011. Alginate microspheres encapsulated with Autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129, 107-114.

 33- Maleki, M., Karimi, G., Tafaghodi, M., Raftari, S., Nahidi, Y., 2012. Comparison of Intralesional 2% zinc sulfate and Glucantime injection in treatment of acute cutaneous Leishmaniasis. Indian Journal of Dermatology, 57, 118-122.

34- Tafaghodi, M., Eskandari, M., 2012. The mucosal adjuvant potential of cross-linked dextran microspheres (CDM) as dry powder. Iranian Journal of Basic Medical Sciences, 15, 873-879.

35- Moghadam Aryaee, F., Tafaghodi, M., 2012. Mucosal adjuvant potential of Quillaja saponins and cross-linked dextran microspheres, co-administered with liposomes encapsulated with tetanus toxoid. Iranian Journal of Pharmaceutical Research, 11(3), 723-732.

36- Khodaverdi, E., Tafaghodi, M., Ganji, F., Abnoos, K., Naghizadeh, H., 2012. In vitro insulin release from thermosensitive chitosan hydrogel.  AAPS PharmSciTech, 13, 460-466.

37- Tafaghodi, M., Saluja, V., Kersten, G.F.A., Kraan, H., Slütter, B., Amorij, J.-P., Jiskoot W., 2012. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics. Vaccine, 30, 5341-5348.

38- Moghimipour, E., Tafaghodi, M., Balouchi, A., Handali, S., 2013. Formulation and in vitro Evaluation of Topical Liposomal Gel of Triamcinolone Acetonide. Research Journal of Pharmaceutical, Biological and Chemical Sciences (RJPBCS), 4, 101-107.

39- Hosseinzadeh, H., Tafaghodi, M., Moosavi, M.J., Taghiabadi, E., 2013. Effect of Aqueous and Ethanolic Extracts of Nigella sativa Seeds on Milk Production in Rats. JAMS Journal of Acupuncture and Meridian Studies, 6, 18-23. 

40- Zarifpour, M., Hadizadeh, F., Iman, M., Tafaghodi, M., 2013. Preparation and characterization of trimethylchitosan (TMC) nanospheres encapsulated with tetanus toxoid. Pharmaceutical Sciences, 1(2), 13-18.

41- Dehghan, S., Tavassoti Kheiri, M., Tabatabaiean, M., Darzi, S., Tafaghodi, M., 2013. Dry-powder form of chitosan nanospheres containing infulenza virus and adjuvants for nasal immunization. Archives of Pharmacal Research, 36:981-992.

42- Ganji, F., Khodaverdi, E., Tafaghodi, M., Sadoogh, M., 2013. Effects of Formulation Properties on Sol-Gel Behavior of Chitosan/glycerolphosphate Hydrogel. Iranian Polymer Journal, 22:785-790.

43- Khodaverdi, E., Tafaghodi, M., Beizaei, S., Abnous, Kh., Alibolandi, M., and Hadizadeh, F., 2013. Preparation and Characterization of PLGA-PEG-PLGA nanospheres prepared with a new thermogelling method for Insulin Delivery. Journal of Chemical and Pharmaceutical Research, 5, 311-319.

44- Khameneh Bagheri, B., Momen-nejad, M., Tafaghodi, M., 2014. In vivo evaluation of mucoadhesive properties of nanoliposomal formulations upon coating with trimethylchitosan polymer. Nanomedicine Journal, 1(3), 147-154.

45- Mohammadpour, A.H., Nazemian, F., Hasanzadeh, M., Tafaghodi, M., Salari, P., Charkazi, S., Naghibi, M., Shamsara, J., 2014. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation, 25, 73-78.

46- Razavi Rohani, S.S., Abnous, K., Tafaghodi, M., 2014. Preparation and characterization of spray-dried powders intended for pulmonary delivery of Insulin with regard to the selection of excipients. International Journal of Pharmaceutics, 465, 464-478.

47- Tafaghodi, M., Kersten, G.F.A, Jiskoot, W., 2014. Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethyl chitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate. Nanomedicine Journal, 1(4), 220-228.

48- Hosseinzadeh, H., Tafaghodi, M., Abedzadeh, S., Taghiabadi, E., 2014. Effect of Aqueous and Ethanolic Extracts of Pimpinella anisum L. Seeds on Milk Production in Rats. Journal of Acupuncture and Meridian Studies, 7(4), 211-216.

49- Ghoochi Atashbeyk, D., Khameneh Bagheri, B., Tafaghodi, M., Fazly Bazzaz, B.S., 2014. Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid. Pharmaceutical Biology, 52 (11), 1423-1428.

50- Mohajer, M., Khameneh, B., Tafaghodi, M., 2014. Preparation and characterization of PLGA nanospheres loaded with inactivated influenza virus, CpG-ODN and Quillaja saponin. Iranian Journal of Basic Medical Sciences, 17, 722-726.

51- Khodaverdi, E., Heidari, Z., Sajadi Tabassi, S.A., Tafaghodi, M., Alibolandi, M., Mirzazadeh Tekie, F.S., Khameneh, B., Hadizadeh, F., 2014. Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property. AAPS PharmSciTech, 16(1), 141-149.

52- Dehghan, S., Tafaghodi, M., Bolourieh, T., Mazaheri, V., Torabi, A., Abnous, KH., Tavassoti Kheiri, M., 2014. Nasal immunaization against influenza by chitosan nanospheres encapsulated with Influenza whole virus and adjuvants in dry-powder form. International Journal of Pharmaceutics, 475, 1-8.

53- Kazemi-Beydokhti, A., Zinali heris, S., Tafaghodi, M., Jaafari, M.R., Hatamipoor, M., 2014. Microwave functionalized single-walled carbon nanotube as nanocarrier for the delivery of anticancer drug cisplatin: in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 24(6), 572-578.

54- Moayedian, T., Mosaffa, F., Khameneh-Bagheri, B., Tafaghodi, M., 2015. Combined effects of PEGylation and particle size on uptake of PLGA particles by macrophage cells. Nanomedicine Journal, 2(4), 299-304.

55- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal 2 (4), 249-260.

56- Montaseri, H., Alipour, S., Tafaghodi, M., 2015. Inhalable, large porous PLGA microparticles loaded with pcalitaxel: Preparation, in vitro and in vivo characterization. Journal of Microencapsulation, 32(7), 661-668.

57- Rady Raz, N., Akbarzadeh-T, M.R., Tafaghodi, M., 2015. Bio-inspired Nanonetworks for Targeted Cancer Drug Delivery. IEEE Transaction of Nanobiosience, 14(8), 894-906.

58- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Badiee, A., 2015. The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice. Nanomedicine Journal 2 (4), 249-260.

59- Mehravaran, A., Jaafari, M.R., Jalali, S.A., Khamesipour, A., Tafaghodi, M., Hojatizade, M., Abbasi, A., Badiee, A., 2015. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation. Iranian Journal of Immunology 12 (4), 274.

60- Radvar, M., Moeintaghavi, A., Tafaghodi, M., Ghanbari, H., Fatemi, H., Mokhtari, M.R., Najafi, F., Hoseinipour, Z., Dastmalchi, P., Farazi, F., 2016. Clinical efficacy of herbal mouth wash composed of Salix alba, Malva sylvestris and Althaea officinalis in chronic periodontitis patients. Journal of Herbal Medicine, 6, 24-27.

61- Shiehzadeh, F., Tafaghodi, M., 2016. Dry powder form of polymeric nanoparticles for pulmonary drug delivery. Current Pharmaceutical Design, 22(17), 2549-2560.

62- Amirnasr, M., Fallah-tafti, T., Sankian, M., Rezaei, A., Tafaghodi, M., 2016. Immunization against HTLV-1 with CHT and TMC nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46. Microbial Pathogenesis, 97, 38-44.

63- Alipour, S., Montaseri, H., Nekouian, A.A., Khalili Azad, A., Mohamadpour, A.H., Tafaghodi, M., 2016. Non-invasive endotracheal delivery of paclitaxel loaded alginate microparticles: pharmacokinetic study. Journal of Chemotherapy, 28(5), 411-416.

64- Tafaghodi, M., Jaafari, M-R. Eskandari, M., Khamesipour, A., 2016. Immunization against cutaneous leishmaniasis by Alginate microspheres loaded with Autoclaved Leishmania major (ALM) and Quillaja saponins. Iranian Journal of Pharmaceutical Research, 15(2), 573-581.

65- Karimi, S.M., Sankian, M., Khademi, F., Tafaghodi, M., 2016. Chitosan (CHT) and trimethylchitosan (TMC) nanoparticles as adjuvant/delivery system for parenteral and nasal immunization against Mycobacterium tuberculosis (MTb) ESAT-6 antigen. Nanomedicine Journal, 3(4), 223-229.

66- Khademi, F., Yousefi-Avarvand, A., Derakhshan, M., Tafaghodi, M., 2016. Immunogenicity of ESX family antigens of Mycobacterium tuberculosis: an overview. Austin Clinical Microbiology, 1(2), 1-5.

66- Amini, Y., Moradi, B., Tafaghodi, M., Meshkat, Z., Ghazvini, K., Fasihi-Ramandi, M., 2016. TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulated strong cellular immunity in mice. Biotechnology and Bioprocess Engineering, 21(5):653-658.

67- Mosafer, J., Teymouri, M., Abnous, KH., Tafaghodi, M., Ramezani, M., 2016. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cancer cells compared with L929 normal cells. Materials Science and Engineering C, 72, 123-133.

68- Mosafer, J., Teymouri, M., Abnous, KH., Tafaghodi, M., Jafarzadeh, H., Ramezani, M., 2016. Preparation and characterization of uniform-sized PLGA nanospheres encapsulated with oleic acid-coated magnetic-Fe3O4 nanoparticles for simultaneous diagnostic and therapeutic applications. Colloids and Surfaces A, 514, 146-154.

69- Mosafer, J., Abnous, Kh., Tafaghodi, M., Ramezani, M., 2017. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy. European Journal of pharmaceutics and Biopharmaceutics, 113, 60-74.

70- Khademi, F., Yousefi-Avarvand, A., Derakhshan, M., Meshkat, Z., Tafaghodi, M., Ghazvini, K., Sankian, M., 2016. Mycobaterium Tuberculosis HspX/EsxS fusion protein: The study of gene cloning, protein expression and purification in Escherechia coli. Reports of Biochemistry and Molecular Biology, 6(1), 15-21.

71- Pirouzmand, H., Khameneh, B., Tafaghodi, M., 2016. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pharmaceutical Biology, 55(1), 212-217.

72- Amini, Y., Tafaghodi, M., Amel Jamehdar, S., Meshkat, Z., Moradi, B., Sankian, M., 2017. Heterologous expression, purification and characterization of the HspX, Ppe44 and EsxV proteins of Mycobacterium tuberculosis. Reports of Biochemistry and Molecular Biology, 6(2), 125-130.

73- Khodaverdi, E., Nade Ali, Z., Tafaghodi, M., Khameneh, B., Kamali, H., Hadizadeh, F., 2017. In Vitro Evaluation of PLGA-PEG-PLGA Microspheres for Sustained Release of Insulin. International Journal of ChemTech Research, 10(9), 1018-1025.

74- Najafi, A., Tafaghodi, M., Sankian, M., Amini, Y., Ghazvini, K., 2017. Cloning, Expression and Refolding of PPE17 protein of mycobacterium tuberculosis as a Promising Vaccine Candidate. Iranian Journal of Basic Medical Sciences (In Press).

75- Amini, Y., Amel Jamehdar, S., Sadri, K., Zare, S., Musavi, D., Tafaghodi, M., 2017. Evaluation of different methods to determine the encapsulation efficiency of proteins in PLGA nanoparticles. Bio-Medical Materials and Engineering, 28(6), 613-620.

76- Khademi, F., Derakhshan, M., Yousefi-Avarvand, A., Tafaghodi, M., Soleimanpour, S., 2018. Multistage subunit vaccines against Mycobacterium tuberculosis: An alternative vaccine or BCG-prime boost?  Expert Review of Vaccines, 17(1), 31-44.

77- Yousefi-Avarvand, A., Vaez, H., Tafaghodi, M., Sahebkar, A.H., Arzanlou, M., Khademi, F., 2018. Antibiotic Resistance of Helicobacter pylori in the Iranian Children: A Systematic Review and Meta-Analysis. Microbial Drug Resistance (In Press).

78- Khademi, F., Yousefi-Avarvand, A., Derakhshan, M., Tafaghodi, M., 2018. Potential of polymeric particles as a future vaccine delivery system/adjuvant for parenteral and non-parenteral immunization against tuberculosis: A systematic review. IJBMS, 21(2), 116-123.

79- Dehghan, S., Kheiri, M.T., Abnous, Kh., Tafaghodi, M., 2018. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits. Microbial Pathogenesis, 115, 74-85.

80- Salarbashi, D., Tafaghodi, M., Fazly Bazzaz, B.S., 2018. Biodegradable soluble soybean polysaccharide/TiO2 nanocomposite film for food application. Carbohydrate polymers, 186, 384-393.

81- Salarbashi, D., Tafaghodi, M., Fazly Bazzaz, B.S., Jafari, B., 2018. Development and characterization of eco-friendly soluble soybean polysaccharide/2 TiO2 nanoparticle bionanocomposites. International Journal of Biological Macromolecules, 112, 852-861.

82- Khademi, F., Derakhshan, M., Tafaghodi, M., 2018. Nasal delivery of HspX/EsxS fused antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity in BALB/c mice Vaccine. Microbial Pathogenesis (In Press).

83- Khademi, F., Yousefi-Avarvand, A., Derakhshan, M., Abbaspour, M.R., Sadri, K., Tafaghodi, M., 2018. Formulation and optimization of a new cationic lipid-modified PLGA nanoparticle as delivery system for Mycobacterium tuberculosis HspX/EsxS fusion protein: A factorial design. Iranian Journal of Pharmaceutical Research (In Press).

84-       Gholami, L., Kazemi Oskuee, R., Tafaghodi, M., Ramezani Farkhani, A., Darroudi, M.

 2018. Green facile synthesis of low-toxic superparamagnetic iron oxide nanoparticles (SPIONs) and their cytotoxicity effects toward Neuro2A and HUVEC cell lines. Ceramics International, 44(8), pp. 9263-9268.

85- Mosafer, J., Sabbaghi, A.H., Dehghan, S., Tafaghodi, M., 2018. Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization. Asian Journal of Pharmaceutical Sciences (In Press).

86- Mosafer, J., Mohammadamini, Z., Komeilinezhad, A., Badiee, A., Tafaghodi, M., 2018. Immunization against PR8 influenza virus with chitosan-coated ISCOMATRIX nanoparticles. Artificial Cells, Nanomedicine and Biotechnology (In Press).

87- Gholami, L., Tafaghodi, M., Abbasi, B., Daroudi, M., Kazemi Oskuee, R., 2017. Theranostic chitosan nanospheres: a promising tool for glioblastoma diagnosis and therapy.  Journal of Cellular Physiology (In Press).

88- Salarbashi, D., Tafaghodi, M., 2018. An update on physicochemical and functional properties of newly seed gums. International Journal of Biological Macromolecules, 119, 1240-1247.

89- Mousavi, D., Maghsoodi, F., Panahandeh, F., Yazdian-Robati, R., Reisi-Vanani, A., Tafaghodi, M., 2018. Reduction-responsive biodegradable poly(ethylene glycol)-b-poly(Ɛ-caprolactone) (PEG-SS-PCL) nanomicelles loaded with superparamagnetic iron oxide (SPIO) nanoparticles (NPs) for combined tumor-targeted delivery of doxorubicin. Materials Science and Engineering C, 92, 631-643.

90- Yousefi avarvand, A., Khademi, F., Tafaghodi, M., Moradi, B., Ahmadipour, Z., Meshkat, Z., 2018. HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview. Frontiers in Biology (In Press).

91- Kabiri, M., Sankian, M., Hosseinpour, M., Tafaghodi, M., 2018. The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1. International Journal of Pharmaceutics, 509, 404-414.

92- Salarbashi, D., Tafaghodi, M., Hanachi, P., Ghayour-Mobarhan, M., Fazly Bazzaz, B.S., 2018. Characterization of a green nanocomposite prepared from soluble soy bean polysaccharide/ Cloisite 30B and evaluation of its toxicity. International Journal of Biological Macromolecules, 120, 109-118.

 

 Submitted Papers

1- Hadizadeh, F., Khodaverdi, E., Javan, M., Tafaghodi, M., Sajadi Tabassi, S.A., Chamani, J., Khameneh, B., Mirzazadeh Tekie, F.S., 2018. Sustained Drug Delivery System for Insulin using Supramolecular Hydrogels Composed of Tri-block Copolymers. Submitted to IJPR.

2- Hojatizad, M., Soleymani, M., Tafaghodi, M., Badiee, A., Chavoshian, O., Jaafari, M.R., 2018. Preparation and characterization of chitosan nanoparticles loaded with whole Leishmania lysate (WLL) and soluble Leishmania antigen (SLA), and evaluation of induced immune response in a mouse model of leishmaniasis. Submitted to Iranian Journal of Immunology.

2- Hojatizade, M., Barzegar, S., Tafaghodi, M., Badiee, A., Chavoshian, O., Jaafari, M.R., 2018. Immunization against leishmaniasis by trimethylchitosan nanoparticles loaded with whole Leishmania lysate (WLL) and soluble Leishmania antigen (SLA) in a mouse model. Submitted to IJPR.

4- Khademi, F., Derakhshan, M., Tafaghodi, M., 2018. Evaluation of PLGA:DDA hybrid nanoparticles and MPLA as delivery system/adjuvant for immunization against a novel multistage subunit vaccine of Mycobacterium tuberculosis. Submitted to IJBMS.

5- Shiezadeh, F., Laal-dehghani, M., Mashhoori, F., Fazly bazzaz, B.S., Imenshahidi, M., Tafaghodi, M., 2018. Pulmonary delivery of gentamycin sulfate by PLGA porous particles. Submitted to Aerosol Science & Technology.

6- Kabiri, M., Sankian; M., Tafaghodi, M., Saberi, M.R., Moghadam, M., 2018. The alternative approach to increase the expression level of fusion epitope: Helical or flexible linkers. Submitted to Molecular Biology Reports.

7- Salarbashi, D., Tafaghodi, M., Mohammadpour, A., 2018.  Environment-friendly green composites based on soluble soybean polysaccharide: A review. Submitted to Carbohyrate Polymer.

 8- Mansury, D., Ghazvini, K., Amini, Y., Amel Jamehdar, S., Nikpoor, A.R., Badiee, A., Tafaghodi, M., Jaafari, M.R., 2018. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing three fusion proteins of HspX, PPE44 and EsxV. Submitted to Immunology Letters.

9- Yousefi-Avarvand, A., Khademi, F., Tafaghodi, M., 2018.Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX, PlusCOM nanoadjuants after subcutaneous administration in mice. Submitted to …

 10- Khademi, Farzad; Derakhshan, Mohammad; Yousefi-Avarvand, Arshid; Najafi, Adel; Tafaghodi, Mohsen; 2018. Evaluation of PLGA:DDA hybrid nanoparticles and MPLA as delivery system/adjuvant for immunization against a novel multistage subunit vaccine of Mycobacterium tuberculosis. Submitted Journal of Applied Microbiology.

11- Kabiri, M., Sankian, M., Sadri, K., Tafaghodi, M., 2018. Robust immune responses against HTLV-1 by delivery of novel multi-epitope vaccine in PLGA nanoparticles. Submitted to European Journal of Pharmaceutics and Biopharmaceutics.

12- Khodaverdi, E., …, Tafaghodi, M., 2018. An In-situ Forming Gel Formulation of Growth Hormone Using PCL-PEG-PCL Thermosensitive Triblock: Preparation and In-vitro Release Study. Submitted to Journal of Macromolecular Science, Part A: Pure and Applied Chemistry.

 

Conference presentations

1- Tafaghodi, M. Shokouhi Nejad, H., 1995. Evaluation of different methods of determination of poor soluble substances. Proceeding of the 2nd congress of Iranian pharmacy students, Mashhad, Iran.

2- Moghimipour E., Dehghan G. and Tafaghodi M., 1998. The study of HPMC concentrations on physical properties of coated tablets. Proceeding of the 6th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

3- Tafaghodi M., Rahimizadeh M., Hassanzadeh M., 2000. Isolation and characterization of alkaloids of Hyoscyamus insanus. Proceeding of the 7th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

4- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2000. Formulation and characterization of liposomes containing tetanus toxoid. Proceeding of the 7th Iranian Congress of Pharmaceutical Sciences, Mashhad, Iran.

5- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R., 2002. Preparation and characterization of alginate microspheres encapsulated with tetanus toxoid for nasal delivery. Proceeding of the 8th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

6- Tafaghodi, M., Diwan, M., Samuel, J., Jaafari, M.R., Sajadi Tabasi, S.A., 2002. Increasing the immune responses by co-delivery of tetanus toxoid and CpG ODN encapsulated in PLGA nanospheres­. Proceeding of the 8th Iranian Congress of Pharmaceutical Sciences, Shiraz, Iran.

7- Tafaghodi, M., Zakavi, S.R., Sajadi Tabasi, S.A., Jaafari, M.R., Momen Nejad, H., 2002. Gamma-Scintigraphy as a novel method to study the distribution and clearance rate of different mucoadhesive nasal delivery systems. Proceeding of the 6th Annual Meeting of Nuclear Medicine, Mashhad, Iran.

8- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2003. Nasal immunization using alginate microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.

9- Sajadi Tabasi, S.A., Tafaghodi, M., Jaafari, M.R.., 2003. Nasal immunization using cross-linked dextran microspheres encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.

10- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabasi, S.A., 2003. Nasal immunization using neutral, cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid (TT). Proceeding of the 1st Congress of New Drug Delivery Systems, Tehran, Iran.........................................................................

11- Tafaghodi, M., Samuel, J., Diwan, M., Sajadi, S.A., Jaafari, M.R., 2003. Utilization of particulate and immunomodulating adjuvants for enhancement of immune response against tumors antigenic markers. Proceeding of the 3rd Congress of National Biotechnology, Mashhad, Iran.

12- Tafaghodi, M., Sajadi Tabasi, S.A., Jaafari, M.R.., 2006. Nasal immunization studies by alginate and cross-linked dextran microspheres and PLGA nanospheres encapsulated with tetanus toxoid (TT). Proceeding of the 10th Iranian Congress of Pharmaceutical Sciences, Tehran, Iran.

13- Tafaghodi, M., Sajadi Tabasi, S.A., Kharazizadeh, M., 2007. Preparation and characterization of PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 3rd Congress of New Drug Delivery Systems, Tehran, Iran.

14- Tafaghodi, M., Hadizadeh, H., Farahmand, F., 2007. Determination of encapsulation efficiency of fluorescent tetanus toxoid in microsphere and Liposome drug delivery systems by spectrofluorimetery method. Proceeding of the 3rd Congress of New Drug Delivery Systems, Tehran, Iran.

15- Tafaghodi, M., Jaafari, M.R., Amin, M.R., 2007. Nasal Immunization Studies in Rabbits by Anionic and Chitosan Coated Liposomes Encapsulated with Tetanus Toxoid as a Model Antigen. Proceeding of the 1st Vaccine Congress, Amsterdam, Netherland.

16- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2008. Preparation, characterization and immunization studies with PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. Proceeding of the 11th Iranian Congress of Pharmaceutical Sciences, Kerman, Iran.

17- Tafaghodi, M., 2009. Nanoparticulate drug delivery systems as vaccine adjuvant and delivery system. Proceeding of the Nanodrugs, nano-biotechnology, nano-biosensors and nano-materials in medical sciences. Mashhad, Iran.

18- Tafaghodi, M., Jaafari, M.R., Sajadi, S.A., Khamesipour, A., Amiri, N., 2009. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. ICRC 2009, Zanjan, Iran.

19- Tafaghodi, M., Mohaghegh, M., 2009. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit. ICRC 2009, Zanjan, Iran. 

20- Tafaghodi, M., Jaafari, M.R., Sajadi Tabasi, S.A., 2009. Induction of immune responses against leishmaniasis by alginate microspheres encapsulated with autoclaved Leishmania major (ALM) antigen and CpG-ODN.  Proceeding of the 3rd Modern vaccine adjuvant and delivery systems, Vienna, Austeria.

21- Tafaghodi, M., Jiskoot, W., Saluja, V., 2011. Hepatitis B surface antigen (HBsAg) nanoparticles coated with chitosan and trimethyl chitosan (TMC): impact of formulation on physicochemical and immunological characteristics.

 22- Tafaghodi, M., 2016. Polymer based nanoparticles as adjuvant/vaccine delivery system for systemic and mucosal immunizations. 13th International Congress of Immunology and allergy of Iran. Tabriz, Iran.

Last update: Dec., 2017